COCHLEAR LTD ADR 1/2/O.N. (OC50 F) stock market data APIs
€75.4002
0(0%)
as of January 19, 2026
Try our APIs with
free plan!
COCHLEAR LTD ADR 1/2/O.N. Financial Data Overview
Price chart is built with
Anychart
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. The company offers cochlear implant systems, sound processor upgrades, bone conduction systems, and other products. It also provides cochlear nucleus systems, including Nucleus sound processors, smart bimodal hearing solution, and Nucleus implants; cochlear Baha systems comprising Baha 6 max sound processor and Baha implant; and accessories, such as wireless devices and Nucleus water-safe accessories. The company was founded in 1981 and is headquartered in Sydney, Australia.
Prev. Close
75.4002
Open
75.4002
High
75.4002
Low
75.4002
52 wk Range
66.5346-94.1379
Market Cap
10 182 M
P/E Ratio
44.7059
Shares Outstanding
131 M
Revenue
2 343 M
Dividends (Yield)
0.0566
Beta
0.509
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get COCHLEAR LTD ADR 1/2/O.N. data using free add-ons & libraries
Get COCHLEAR LTD ADR 1/2/O.N. Fundamental Data
COCHLEAR LTD ADR 1/2/O.N. Fundamental data includes:
- Net Revenue: 2 343 M
- EBITDA: 574 M
- Earnings Per Share: 1
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
COCHLEAR LTD ADR 1/2/O.N. News
New
Cochlear Announces Availability of Nucleus Nexa System to US Military Veterans
LONE TREE, Colo., Jan. 8, 2026/PRNewswire/ -- Cochlear, the global leader in implantable hearing solutions, is proud to announce that the groundbreaking Nucleus® Nexa® System is now available to eli...
Is Now The Time To Put Cochlear (ASX:COH) On Your Watchlist?
It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story even if these companies are loss-making. Sometimes these stories can cloud the mind...
Could The Market Be Wrong About Cochlear Limited (ASX:COH) Given Its Attractive Financial Prospects?
It is hard to get excited after looking at Cochlear's (ASX:COH) recent performance, when its stock has declined 7.6% over the past three months. However, a closer look at its sound financials might ca...
Cochlear Limited (ASX:COH) is a favorite amongst institutional investors who own 57%
Key Insights Given the large stake in the stock by institutions, Cochlear's stock price might be vulnerable to their trading decisions 50% of the business is held by the top 17 shareholders Recent pu...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
